Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 06 2019
Historique:
received: 22 01 2019
accepted: 23 03 2019
pubmed: 5 4 2019
medline: 24 6 2020
entrez: 5 4 2019
Statut: epublish

Résumé

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus. Recent ZIKV outbreaks have produced serious human disease, including neurodevelopmental malformations (congenital Zika syndrome) and Guillain-Barré syndrome. These outcomes were not associated with ZIKV infection prior to 2013, raising the possibility that viral genetic changes could contribute to new clinical manifestations. All contemporary ZIKV isolates encode an N-linked glycosylation site in the envelope (E) protein (N154), but this glycosylation site is absent in many historical ZIKV isolates. Here, we investigated the role of E protein glycosylation in ZIKV pathogenesis using two contemporary Asian-lineage strains (H/PF/2013 and PRVABC59) and the historical African-lineage strain (MR766). We found that glycosylated viruses were highly pathogenic in

Identifiants

pubmed: 30944176
pii: JVI.00113-19
doi: 10.1128/JVI.00113-19
pmc: PMC6613755
pii:
doi:

Substances chimiques

CLEC4M protein, human 0
Cell Adhesion Molecules 0
DC-specific ICAM-3 grabbing nonintegrin 0
Lectins, C-Type 0
Receptors, Cell Surface 0
Viral Envelope Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI106695
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI129431
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007419
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Exp Med. 2003 Apr 7;197(7):823-9
pubmed: 12682107
EMBO Rep. 2003 Jul;4(7):723-8
pubmed: 12783086
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
J Gen Virol. 2004 Dec;85(Pt 12):3637-45
pubmed: 15557236
J Virol. 2005 Jul;79(13):8339-47
pubmed: 15956579
J Virol. 2005 Nov;79(21):13262-74
pubmed: 16227249
J Virol. 2006 Feb;80(3):1290-301
pubmed: 16415006
J Biol Chem. 2006 Dec 1;281(48):37183-94
pubmed: 17001080
J Virol. 2006 Dec;80(24):12149-59
pubmed: 17035317
J Virol. 2007 Jul;81(13):7136-48
pubmed: 17459925
Virus Res. 2008 Jul;135(1):64-71
pubmed: 18405996
J Virol. 2008 Jul;82(13):6631-43
pubmed: 18448542
J Mol Med (Berl). 2008 Aug;86(8):861-74
pubmed: 18458800
Emerg Infect Dis. 2008 Aug;14(8):1232-9
pubmed: 18680646
Virology. 2009 Apr 25;387(1):222-8
pubmed: 19249803
J Gen Virol. 2009 Sep;90(Pt 9):2097-106
pubmed: 19494052
Am J Trop Med Hyg. 2010 Apr;82(4):696-704
pubmed: 20348522
J Immunol. 2011 Feb 15;186(4):2192-200
pubmed: 21239715
J Gen Virol. 2011 Oct;92(Pt 10):2286-96
pubmed: 21733886
PLoS Negl Trop Dis. 2012;6(2):e1477
pubmed: 22389730
PLoS Negl Trop Dis. 2012;6(2):e1486
pubmed: 22389731
Curr Opin Virol. 2012 Apr;2(2):168-75
pubmed: 22445964
Trends Immunol. 2013 Oct;34(10):482-6
pubmed: 23608151
J Gen Virol. 2013 Oct;94(Pt 10):2249-58
pubmed: 23824303
MBio. 2013 Nov 19;4(6):e00873-13
pubmed: 24255124
Viruses. 2013 Dec 30;6(1):69-88
pubmed: 24381034
PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2636
pubmed: 24421913
Curr Protoc Microbiol. 2013 Nov 05;31:15D.3.1-15D.3.18
pubmed: 24510289
Euro Surveill. 2014 Mar 06;19(9):null
pubmed: 24626205
Emerg Infect Dis. 2014 Jun;20(6):1085-6
pubmed: 24856001
Genome Announc. 2014 Jun 05;2(3):null
pubmed: 24903869
PLoS Pathog. 2014 Oct 02;10(10):e1004386
pubmed: 25275316
Vector Borne Zoonotic Dis. 2014 Dec;14(12):862-5
pubmed: 25514122
Nature. 2015 Apr 2;520(7545):109-13
pubmed: 25581790
Mem Inst Oswaldo Cruz. 2015 Jun;110(4):569-72
pubmed: 26061233
J Virol. 2015 Sep;89(17):8880-96
pubmed: 26085147
Emerg Infect Dis. 2015 Oct;21(10):1885-6
pubmed: 26401719
Virology. 2016 Jan 15;488:108-19
pubmed: 26629951
Emerg Microbes Infect. 2016 Mar 16;5:e22
pubmed: 26980239
Lancet. 2016 May 21;387(10033):2125-2132
pubmed: 26993883
Science. 2016 Apr 15;352(6283):345-349
pubmed: 27013429
Am J Trop Med Hyg. 2016 Jun 1;94(6):1362-1369
pubmed: 27022155
N Engl J Med. 2016 Apr 21;374(16):1552-63
pubmed: 27028561
Science. 2016 Apr 22;352(6284):467-70
pubmed: 27033547
Cell Host Microbe. 2016 May 11;19(5):720-30
pubmed: 27066744
Emerg Infect Dis. 2016 May;22(5):933-5
pubmed: 27088323
Cell Host Microbe. 2016 May 11;19(5):561-5
pubmed: 27091703
Genome Announc. 2016 May 12;4(3):null
pubmed: 27174284
Cell Host Microbe. 2016 Jun 8;19(6):882-90
pubmed: 27212660
Genome Announc. 2016 Aug 18;4(4):null
pubmed: 27540058
Nat Rev Microbiol. 2016 Nov;14(11):707-715
pubmed: 27573577
MBio. 2016 Oct 11;7(5):
pubmed: 27729507
EMBO Rep. 2016 Dec;17(12):1766-1775
pubmed: 27797853
MBio. 2017 Mar 7;8(2):
pubmed: 28270583
PLoS Pathog. 2017 Mar 9;13(3):e1006258
pubmed: 28278235
Nature. 2017 May 25;545(7655):482-486
pubmed: 28514450
Nature. 2017 Jun 15;546(7658):406-410
pubmed: 28538727
Nature. 2017 Jun 15;546(7658):411-415
pubmed: 28538734
Nat Microbiol. 2017 Nov;2(11):1558-1570
pubmed: 28827581
J Virol. 2017 Nov 14;91(23):
pubmed: 28931684
Nat Microbiol. 2017 Nov;2(11):1462-1470
pubmed: 28970482
Science. 2017 Nov 17;358(6365):933-936
pubmed: 28971967
Cell Rep. 2017 Oct 31;21(5):1180-1190
pubmed: 29091758
Lancet Infect Dis. 2018 May;18(5):e172-e182
pubmed: 29150310
J Infect Dis. 2017 Dec 16;216(suppl_10):S897-S905
pubmed: 29267923
J Infect Dis. 2017 Dec 16;216(suppl_10):S935-S944
pubmed: 29267925
Virology. 2018 Feb;515:191-202
pubmed: 29304471
Nat Commun. 2018 Jan 29;9(1):414
pubmed: 29379028
MBio. 2018 Feb 20;9(1):
pubmed: 29463651
J Virol. 2018 Aug 16;92(17):
pubmed: 29899104
Front Cell Infect Microbiol. 2018 Jul 10;8:239
pubmed: 30042931
Nature. 2018 Aug;560(7720):573-581
pubmed: 30158602
iScience. 2018 Mar 23;1:97-111
pubmed: 30227960
Nat Rev Microbiol. 2019 Mar;17(3):131-139
pubmed: 30617340
Infect Genet Evol. 2019 Apr;69:22-29
pubmed: 30658214
Trends Microbiol. 2019 May;27(5):381-383
pubmed: 30826180
PLoS Med. 2019 Mar 5;16(3):e1002755
pubmed: 30835728
PLoS Negl Trop Dis. 2019 Apr 17;13(4):e0007343
pubmed: 30995223
Am J Trop Med Hyg. 1982 Jul;31(4):830-6
pubmed: 6285749
J Gen Virol. 1993 May;74 ( Pt 5):931-5
pubmed: 8388021

Auteurs

Derek L Carbaugh (DL)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Ralph S Baric (RS)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Helen M Lazear (HM)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA helen.lazear@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH